
On Monday, December 6, 2021 Mayo Clinic’s leading experts on COVID-19 treatments and therapeutics. Dr. Andrew Badley and Dr. Raymund Razonable discussed the new antiviral pills for the treatment of COVID, as well as existing therapies like monoclonal antibodies and other existing and emerging therapeutics.
Journalists who have already registered on the News Network can log into their accounts to download a recording of the Zoom briefing found at the end of this post.
Journalists who would like to access the media briefing video can register with the News Network here.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date.
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
Learn more about tracking COVID-19 and COVID-19 trends.
DEAR MAYO CLINIC: The Food and Drug Administration recently approved two new COVID-19 vaccines from Pfizer and Moderna. What are the recommendations for who should ...
Influenza, COVID-19, the common cold and respiratory syncytial virus (RSV) are among the respiratory viruses that will be circulating this fall and winter seasons. These ...
If you haven't had the flu in a few years, there's a reason. As Dr. Nipunie Rajapakse, a pediatric infectious diseases physician with the Mayo Clinic Children's Center, shares, ...